Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhanqi Liu

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
The Journal of Experimental Medicine|August 10, 2016
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growthLakmali Atapattu, Nayanendu Saha, Chanly Chheang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigenAndrew M Scott, Niall Tebbutt, Fook-Thean Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptorsAndrew M Scott, Fook-Thean Lee, Niall Tebbutt, et al.
Ebiomedicine|February 28, 2021
A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controlsJames H McMahon, Jennifer M Zerbato, Jillian S Y Lau, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
The Journal of Experimental Medicine|August 10, 2016
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growthLakmali Atapattu, Nayanendu Saha, Chanly Chheang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigenAndrew M Scott, Niall Tebbutt, Fook-Thean Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptorsAndrew M Scott, Fook-Thean Lee, Niall Tebbutt, et al.
Ebiomedicine|February 28, 2021
A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controlsJames H McMahon, Jennifer M Zerbato, Jillian S Y Lau, et al.
Pageof 5